{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:29:44Z","timestamp":1760549384355},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1097\/mnm.0b013e3283620d5e","type":"journal-article","created":{"date-parts":[[2013,5,15]],"date-time":"2013-05-15T16:56:40Z","timestamp":1368637000000},"page":"733-740","source":"Crossref","is-referenced-by-count":17,"title":["Evaluation of extraprostatic disease in the staging of prostate cancer by F-18 choline PET\/CT"],"prefix":"10.1097","volume":"34","author":[{"given":"Ferdinando","family":"Calabria","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agostino","family":"Chiaravalloti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Tavolozza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiana","family":"Ragano-Caracciolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orazio","family":"Schillaci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-2-20210212","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/canjclin.55.1.10","article-title":".Cancer statistics, 2005.","volume":"55","author":"Jemal","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"R2-2-20210212","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1754-9485.2010.02178.x","article-title":"Pilot comparison of F-fluorocholine and F-fluorodeoxyglucose PETCT with conventional imaging in prostate cancer.","volume":"54","author":"Beauregard","year":"2010","journal-title":"J Med Imaging Radiat Oncol"},{"key":"R3-2-20210212","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00259-006-0150-2","article-title":".18FFluorocholine PETCT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients.","volume":"33","author":"Cimitan","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R4-2-20210212","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/MNM.0b013e3283369654","article-title":".Detection of bronchioloalveolar cancer by means of PETCT and 18F-fluorocholine, and comparison with 18F-fluorodeoxyglucose.","volume":"31","author":"Balogova","year":"2010","journal-title":"Nucl Med Commun"},{"key":"R5-2-20210212","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1007\/s00259-011-1743-y","article-title":".PET imaging of hepatocellular carcinoma with 18F-fluoroethylcholine and 11C-choline.","volume":"38","author":"Kolthammer","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R6-2-20210212","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/MNM.0b013e328330adc5","article-title":". 18F-choline PETCT physiological distribution and pitfalls in image interpretation: experience in 80 patients with prostate cancer.","volume":"31","author":"Schillaci","year":"2010","journal-title":"Nucl Med Commun"},{"key":"R7-2-20210212","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s11547-008-0263-8","article-title":".Role of whole-body 18F-choline PETCT in disease detection in patients with biochemical relapse after radical treatment for prostate cancer.","volume":"113","author":"Pelosi","year":"2008","journal-title":"Radiol Med"},{"key":"R8-2-20210212","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00259-007-0552-9","article-title":".Evaluation of (18)F-choline PETCT for staging and restaging of prostate cancer.","volume":"35","author":"Husarik","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R9-2-20210212","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.eururo.2007.03.032","article-title":".Detection of lymph-node metastases with integrated 11Ccholine PETCT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy.","volume":"52","author":"Scattoni","year":"2007","journal-title":"Eur Urol"},{"key":"R10-2-20210212","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.nucmedbio.2008.05.006","article-title":".(11)CCholine positron emission tomographycomputed tomography for staging and restaging of patients with advanced prostate cancer.","volume":"35","author":"Tuncel","year":"2008","journal-title":"Nucl Med Biol"},{"key":"R11-2-20210212","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s00259-010-1678-8","article-title":"A case of thymoma detected by 18F-choline positron emission tomographycomputed tomography.","volume":"38","author":"Calabria","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R12-2-20210212","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00259-011-2030-7","article-title":".Influence of PSA, PSA velocity and PSA doubling time on contrast-enhanced 18F-choline PETCT detection rate in patients with rising PSA after radical prostatectomy.","volume":"39","author":"Schillaci","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R13-2-20210212","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.2967\/jnumed.108.061507","article-title":".Influence of trigger PSA and PSA kinetics on 11C-choline PETCT detection rate in patients with biochemical relapse after radical prostatectomy.","volume":"50","author":"Castellucci","year":"2009","journal-title":"J Nucl Med"},{"key":"R14-2-20210212","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1007\/s00259-010-1496-z","article-title":"I Goethals.PET with (18)F-labelled choline-based tracers for tumour imaging: a review of the literature.","volume":"37","author":"Mertens","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R15-2-20210212","doi-asserted-by":"crossref","first-page":"809","DOI":"10.4111\/kju.2011.52.12.809","article-title":".Prostate-specific antigen density as a powerful predictor of extracapsular extension and positive surgical margin in radical prostatectomy patients with prostate-specific antigen levels of less than 10 ngml.","volume":"52","author":"Chang","year":"2011","journal-title":"Korean J Urol"},{"key":"R16-2-20210212","first-page":"353","article-title":"Are PSA density and PSA density of the transition zone more accurate than PSA in predicting the pathological stage of clinically localized prostate cancerUrol O","volume":"26","author":"Giannarini","year":"2008","journal-title":"ncol"},{"key":"R17-2-20210212","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1007\/s00259-007-0686-9","article-title":".The value of 18F-choline PETCT in patients with elevated PSA-level and negative prostate needle biopsy for localisation of prostate cancer.","volume":"35","author":"Igerc","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R18-2-20210212","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.juro.2006.04.015","article-title":". 11C-Choline positron emission tomographycomputerized tomography for tumor localization of primary prostate cancer in comparison with 12-core biopsy.","volume":"176","author":"Martorana","year":"2006","journal-title":"J Urol"},{"key":"R19-2-20210212","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1148\/radiol.09090413","article-title":". 18F choline PETCT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients.","volume":"254","author":"Beheshti","year":"2010","journal-title":"Radiology"},{"key":"R20-2-20210212","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ejca.2009.11.008","article-title":".F18-Fluoroethylcholine combined in-line PET-CT scan for detection of lymph-node metastasis in high risk prostate cancer patients prior to radical prostatectomy: preliminary results from a prospective histology based study.","volume":"46","author":"Steuber","year":"2010","journal-title":"Eur J Cancer"},{"key":"R21-2-20210212","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.eururo.2008.04.030","article-title":". 11C-Choline positron emission tomographycomputerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms.","volume":"54","author":"Schiavina","year":"2008","journal-title":"Eur Urol"},{"key":"R22-2-20210212","first-page":"331","article-title":"Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET.","volume":"44","author":"De Jong","year":"2003","journal-title":"J Nucl Med"},{"key":"R23-2-20210212","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1464-410X.2009.09191.x","article-title":".18F-Fluorocholine positron-emissioncomputed tomography for lymph node staging of patients with prostate cancer: preliminary results of a prospective study.","volume":"106","author":"Poulsen","year":"2010","journal-title":"BJU Int"},{"key":"R24-2-20210212","first-page":"1642","article-title":".Detection and localization of prostate cancer: correlation of (11)C-choline PETCT with histopathologic step-section analysis.","volume":"46","author":"Farsad","year":"2005","journal-title":"J Nucl Med"},{"key":"R25-2-20210212","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/j.1464-410X.2012.11120.x","article-title":"Intermittent hormonal therapy in the treatment of metastatic prostate cancer: a randomized trial.","volume":"110","author":"Mottet","year":"2012","journal-title":"BJU Int"},{"key":"R26-2-20210212","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s11307-009-0239-7","article-title":".The use of F-18 choline PET in the assessment of bone metastases in prostate cancer: correlation with morphological changes on CT.","volume":"12","author":"Beheshti","year":"2010","journal-title":"Mol Imaging Biol"},{"key":"R27-2-20210212","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1002\/pros.20375","article-title":".Prostate-specific antigen induces apoptosis of osteoclast precursors: potential role in osteoblastic bone metastases of prostate cancer.","volume":"66","author":"Goya","year":"2006","journal-title":"Prostate"},{"key":"R28-2-20210212","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/pcan.2010.36","article-title":"Relationship between initial PSA density with future PSA kinetics and repeat biopsies in men with prostate cancer on active surveillance.","volume":"14","author":"Kotb","year":"2011","journal-title":"Prostate Cancer Prostatic Dis"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MNM.0b013e3283620d5e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:19:26Z","timestamp":1620962366000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006231-201308000-00002"}},"subtitle":["can PSA and PSA density help in patient selection?"],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0b013e3283620d5e","relation":{},"ISSN":["0143-3636"],"issn-type":[{"value":"0143-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}